Trademark Search  /  GALAPAGOS

GALAPAGOS

● Live · Registered

U.S. federal trademark · Serial No. 88110392 · Reg. No. 017947150

Mark
GALAPAGOS
Status
Registered
Serial Number
88110392
Registration No.
017947150
Filing Date
August 24, 2018
Registration Date
April 16, 2019
Class(es)
Class 005, Class 042, Class 044

Owners

Galapagos N.V.
03 · Mechelen, BE
Galapagos N.V.
03 · Mechelen, BE
Galapagos N.V.
03 · Mechelen, BE

Goods & Services

[ medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes ]

pharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ] ; biopharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ]

[ medical services; medical and pharmaceutical advisory and consultancy services; gene bank services ]

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "GALAPAGOS" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.